Deferred Cytoreductive Nephrectomy

PROCEDURE2 trials

Sponsors

Fudan University

Conditions

Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaMetastatic Non-Clear Cell Renal Cell CarcinomaMetastatic Renal Medullary Carcinomas

Phase 2

TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell Carcinoma

Not yet recruitingNCT07776717

Fudan UniversityAdvanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma

Start: 2026-08-20End: 2028-12-31Target: 30Updated: 2026-08-20

MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary Carcinomas

Not yet recruitingNCT07816770

Fudan UniversityMetastatic Non-Clear Cell Renal Cell Carcinoma, Metastatic Renal Medullary Carcinomas

Start: 2026-09-20End: 2028-06-30Target: 30Updated: 2026-09-14